Molecular and Cellular Biochemistry

, Volume 290, Issue 1–2, pp 145–151 | Cite as

Effect of tri-o-cresyl phosphate on cytoskeleton in human neuroblastoma SK-N-SH cell



Cytoskeletal components play an important role in maintaining cellular architecture and internal organization, with clear involvement of defining cell shape, in cell division and other cellular processes, such as neurite extension and maintenance. Alterations of cytoskeleton in human neuroblastoma SK-N-SH cells after exposure to different concentrations of tri-ocresyl phosphate (TOCP) for 12 hr were investigated. TOCP decreased the cell viability in a dose-dependent manner; the viability of SK-N-SH was reduced to approximately 50% of baseline after a 12-hour exposure to TOCP at high concentration (5 mM). Biochemical characterization by western blotting revealed that 1 and 5 mM concentrations of TOCP significantly inhibited the expression of neurofilament high molecular weight protein (NF-H), and that 5 mM TOCP inhibited expression of microtubule-associated protein 2c and tau protein, but not β-actin. Indirect immunofluorescence analysis revealed that higher concentrations of TOCP decreased the length of neuritis and changed the structure of microfilaments, which are associated with NF-H. In addition, activities of neuropathy target esterase and acetylcholinesterase were significantly reduced after exposure to 5 mM TOCP for 12 hr. Together, these results suggested that the loss of cytoskeletal components is the early event during the process of TOCP toxicity towards human neuroblastoma SK-N-SH cells.

Key words

human neuroblastoma SK-N-SH cell neurotoxicity cytoskeleton esterase tri-o-cresyl phosphate 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Craig PH, Barth ML: Evaluation of the hazards of industrial exposure to tricresyl phosphate: a review and interpretation of the literature. J Toxicol Environ Health B Crit Rev 2: 281–300, 1999PubMedCrossRefGoogle Scholar
  2. 2.
    Winder C, Balouet JC: The toxicity of commercial jet oils. Environ Res 89: 146–164, 2002PubMedCrossRefGoogle Scholar
  3. 3.
    Smith MI, Elvove I, Valaer PJ, Frazier WH, Mallory GE: Pharmacologic and chemical studies of the cause of the so-called ginger paralysis. US Public Health Rep 45: 1703–1716, 1930Google Scholar
  4. 4.
    Fowler MJ, Flaskos J, McLean WG, Hargreaves AJ: Effects of neuropathic and non-neuropathic isomers of tricresyl phosphate and their microsomal activation on the production of axon-like processes by differentiating mouse N2a neuroblastoma cells. J Neurochem 76: 671–678, 2001PubMedCrossRefGoogle Scholar
  5. 5.
    Abou-Donia MB: The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). Chem Biol Interact 87: 383–393, 1993PubMedCrossRefGoogle Scholar
  6. 6.
    Inoue N, Fujishiro K, Mori K, Matsuoka M: Triorthocresyl phosphate poisoning–a review of human cases. J Univ Occup Environ Health 10: 433–442, 1988Google Scholar
  7. 7.
    Barber D, Correll L, Ehrich M: Comparative effectiveness of organophosphorus protoxicant activating systems in neuroblastoma cells and brain homogenates. J Toxicol Environ Health A 57: 63–74, 1999PubMedCrossRefGoogle Scholar
  8. 8.
    Flaskos J, McLean WG, Fowler MJ, Hargreaves AJ: Tricresyl phosphate inhibits the formation of axon-like processes and disrupts neurofilaments in cultured mouse N2a and rat PC12 cells. Neurosci Lett 242: 101–104, 1998PubMedCrossRefGoogle Scholar
  9. 9.
    Li WW, Casida JE: Organophosphorus neuropathy target esterase inhibitors selectively block outgrowth of neurite-like and cell processes in cultured cell. Toxicol Lett 98: 139–146, 1998PubMedCrossRefGoogle Scholar
  10. 10.
    Carlson K, Ehrich M: Organophosphorus compounds alter intracellular f-actin content in SH-SY5Y human neuroblastoma cells. Neurotoxicology 22: 819–827, 2001PubMedCrossRefGoogle Scholar
  11. 11.
    Wu G, Fang Y, Lu, ZH, Ledeen RW: Induction of axon-like and dendrite-like processes in neuroblastoma cells. J Neurocytol 27: 1–14, 1998PubMedCrossRefGoogle Scholar
  12. 12.
    Hong MS, Hong SJ, Barhoumi R, Burghardt RC, Donnelly KC, Wild JR, Venkatraj V, Tiffany-Castiglioni E: Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds. Toxicol Appl Pharmacol 186: 110–118, 2003PubMedCrossRefGoogle Scholar
  13. 13.
    Nostrandt AC, Ehrich M: Development of a model cell culture system in which to study early effects of neuropathy-inducing organophosphorus esters. Toxicol Lett 60: 107–114, 1992PubMedCrossRefGoogle Scholar
  14. 14.
    Johnson MK: Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch Toxicol 37: 113–115, 1977PubMedCrossRefGoogle Scholar
  15. 15.
    Ehrich M, Correll L, Veronesi B: Acetylcho1inesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Fundam Appl Toxico1 38: 55–63,1997Google Scholar
  16. 16.
    Gorun V, Proinov I, Baltesuc V, Balaban G, Barzu O: Modified Ellman procedure for assay of cholinesterase in crude enzymatic preparations. Anal Biochem 86: 324–326, 1978PubMedCrossRefGoogle Scholar
  17. 17.
    Morgan EW, Yan B, Petersen DR, Greenway D, Parkinson A: Purification and characterization of two rat liver microsomal carboxylesterases (hydrolases A and B). Arch Biochem Biophys 315: 495–512, 1994PubMedCrossRefGoogle Scholar
  18. 18.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275, 1951PubMedGoogle Scholar
  19. 19.
    Cho T, Tiffany-Castiglioni E: Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in SY5Y neuroblastoma cells. J Toxicol Environ Health A 67: 987–1000, 2004PubMedCrossRefGoogle Scholar
  20. 20.
    Roger B, Al-Bassam J, Dehmelt L, Milligan RA, Halpain S: MAP2c, but not tau, binds and bundles f-actin via its microtubule binding domain. Curr Biol 14: 363–371, 2004PubMedCrossRefGoogle Scholar
  21. 21.
    Loomis PA, Howaed TH, Castleberry RP, Binder L: Identification of nuclear tau isoforms in human neuroblastoma cells. Proc Natl Acad Sci USA 87: 8414–8462, 1990Google Scholar
  22. 22.
    Uberti D, Rizzini C, Spano P, Memo M: Characterization of tau proteins in human neuroblastoma SH-SY5Y cell line. Neurosci Lett 235: 149–153, 1997PubMedCrossRefGoogle Scholar
  23. 23.
    Zhao XL, Zhu ZP, Zhang TL, Zhang CL, Yu LH, Xie KQ: Tri-ortho-cresyl phosphate (TOCP) decreases the levels of cytoskeletal proteins in hen sciatic nerve. Toxicol Lett 152: 139–147, 2004PubMedGoogle Scholar
  24. 24.
    Veronesi B, Ehrich M: Differential cytotoxic sensitivity in mouse and human cell lines exposed to organophosphate insecticides. Toxicol Appl Pharmacol 120: 240–246, 1993PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  1. 1.Laboratory of Molecular Toxicology, State Key Laboratory of Integrated Management of Pest Insects and RodentsInstitute of Zoology, Chinese Academy of SciencesBeijingP. R. China
  2. 2.College of BioinformaticsChongqing University of Posts and TelecommunicationsChongqingP. R. China
  3. 3.Institute of ZoologyChinese Academy of SciencesBeijingP.R. China

Personalised recommendations